Related Articles
Type II cyclic guanosine monophosphate-dependent protein kinase inhibits epidermal growth factor receptor activation in different cancer cell lines
Type II cGMP-dependent protein kinase inhibits ligand‑induced activation of EGFR in gastric cancer cells
Small cell lung cancer cells express EGFR and tyrosine phosphorylation of EGFR is inhibited by gefitinib (‘Iressa’, ZD1839)
Type II cGMP-dependent protein kinase directly inhibits HER2 activation of gastric cancer cells
EGFR blockade by tyrosine kinase inhibitor or monoclonal antibody inhibits growth, directs terminal differentiation and induces apoptosis in the human squamous cell carcinoma HN5.